Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcus Quinkler

Showing results (151-160 of 209) with videos related to

Pageof 21
Sort By:
Cancers|February 9, 2020
Effects of Germline CYP2W1*6 and CYP2B6*6 Single Nucleotide Polymorphisms on Mitotane Treatment in Adrenocortical Carcinoma: A Multicenter ENSAT StudyBarbara Altieri, Silviu Sbiera, Sabine Herterich, et al.
The Journal of Clinical Endocrinology and Metabolism|November 15, 2012
The role of surgery in the management of recurrent adrenocortical carcinomaIlknur Erdogan, Timo Deutschbein, Christian Jurowich, et al.
The Journal of Clinical Endocrinology and Metabolism|July 12, 2014
Krebs cycle metabolite profiling for identification and stratification of pheochromocytomas/paragangliomas due to succinate dehydrogenase deficiencySusan Richter, Mirko Peitzsch, Elena Rapizzi, et al.
The Journal of Steroid Biochemistry and Molecular Biology|December 17, 2023
Urine steroid metabolomics as a diagnostic tool in primary aldosteronismAlessandro Prete, Katharina Lang, David Pavlov, et al.
Hypertension (Dallas, Tex. : 1979)|March 9, 2011
Adrenal venous sampling: evaluation of the German Conn's registryOliver Vonend, Nora Ockenfels, Xing Gao, et al.
The Journal of Clinical Endocrinology and Metabolism|July 25, 2014
Novel somatic mutations in the catalytic subunit of the protein kinase A as a cause of adrenal Cushing's syndrome: a European multicentric studyGuido Di Dalmazi, Caroline Kisker, Davide Calebiro, et al.
Journal of Personalized Medicine|April 30, 2021
What Is the Optimal Duration of Adjuvant Mitotane Therapy in Adrenocortical Carcinoma? An Unanswered QuestionVittoria Basile, Soraya Puglisi, Barbara Altieri, et al.
The Journal of Clinical Endocrinology and Metabolism|January 22, 2010
Functional consequences of seven novel mutations in the CYP11B1 gene: four mutations associated with nonclassic and three mutations causing classic 11{beta}-hydroxylase deficiencySilvia Parajes, Lourdes Loidi, Nicole Reisch, et al.
Ebiomedicine|December 21, 2023
Delineating endogenous Cushing's syndrome by GC-MS urinary steroid metabotypingLeah T Braun, Andrea Osswald, Stephanie Zopp, et al.
Annals of Surgery|July 11, 2020
Clinical Presentation, Treatment, and Outcome of Parathyroid Carcinoma: Results of the NEKAR Retrospective International Multicenter StudyChristina Lenschow, Sina Schrägle, Stefan Kircher, et al.
Pageof 21

Showing results (151-160 of 209) with videos related to

Sort By:
Pageof 21
Cancers|February 9, 2020
Effects of Germline CYP2W1*6 and CYP2B6*6 Single Nucleotide Polymorphisms on Mitotane Treatment in Adrenocortical Carcinoma: A Multicenter ENSAT StudyBarbara Altieri, Silviu Sbiera, Sabine Herterich, et al.
The Journal of Clinical Endocrinology and Metabolism|November 15, 2012
The role of surgery in the management of recurrent adrenocortical carcinomaIlknur Erdogan, Timo Deutschbein, Christian Jurowich, et al.
The Journal of Clinical Endocrinology and Metabolism|July 12, 2014
Krebs cycle metabolite profiling for identification and stratification of pheochromocytomas/paragangliomas due to succinate dehydrogenase deficiencySusan Richter, Mirko Peitzsch, Elena Rapizzi, et al.
The Journal of Steroid Biochemistry and Molecular Biology|December 17, 2023
Urine steroid metabolomics as a diagnostic tool in primary aldosteronismAlessandro Prete, Katharina Lang, David Pavlov, et al.
Hypertension (Dallas, Tex. : 1979)|March 9, 2011
Adrenal venous sampling: evaluation of the German Conn's registryOliver Vonend, Nora Ockenfels, Xing Gao, et al.
The Journal of Clinical Endocrinology and Metabolism|July 25, 2014
Novel somatic mutations in the catalytic subunit of the protein kinase A as a cause of adrenal Cushing's syndrome: a European multicentric studyGuido Di Dalmazi, Caroline Kisker, Davide Calebiro, et al.
Journal of Personalized Medicine|April 30, 2021
What Is the Optimal Duration of Adjuvant Mitotane Therapy in Adrenocortical Carcinoma? An Unanswered QuestionVittoria Basile, Soraya Puglisi, Barbara Altieri, et al.
The Journal of Clinical Endocrinology and Metabolism|January 22, 2010
Functional consequences of seven novel mutations in the CYP11B1 gene: four mutations associated with nonclassic and three mutations causing classic 11{beta}-hydroxylase deficiencySilvia Parajes, Lourdes Loidi, Nicole Reisch, et al.
Ebiomedicine|December 21, 2023
Delineating endogenous Cushing's syndrome by GC-MS urinary steroid metabotypingLeah T Braun, Andrea Osswald, Stephanie Zopp, et al.
Annals of Surgery|July 11, 2020
Clinical Presentation, Treatment, and Outcome of Parathyroid Carcinoma: Results of the NEKAR Retrospective International Multicenter StudyChristina Lenschow, Sina Schrägle, Stefan Kircher, et al.
Pageof 21